Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities (such as nursing homes and dialysis centers) who have weakened immune systems.
MRSA infections that occur in otherwise healthy people who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-associated (CA)-MRSA infections. These infections are usually skin infections, such as abscesses, boils, and other pus-filled lesions.
Antibiotic resistance is one of the biggest threats to global health, food security, and development today. A new study shows how superbugs adapt to combat 'last-resort antibiotics'.
Hospital patients who have methicillin-resistant Staphylococcus aureus can prevent future MRSA infections by following a standard bathing protocol after discharge, according to research results published in the February 14 issue of the New England Journal of Medicine.
Researchers analyzing soil from Ireland long thought to have medicinal properties have discovered that it contains a previously unknown strain of bacteria which is effective against four of the top six superbugs that are resistant to antibiotics, including MRSA.
Face masks appear to provide important protection against drug-resistant Staphylococcus aureus bacteria for hog farm workers and for household members to whom they might otherwise transmit the bacteria, according to a study led by scientists at Johns Hopkins Bloomberg School of Public Health.
Therapy dogs help ease stress in young patients with cancer, but can spread methicillin-resistant Staphylococcus aureus, putting vulnerable kids at risk for a serious infection.
Alterations to the respiratory microbiome have been identified as a predisposing factor of interstitial lung diseases. In a study at CHEST 2018, researchers at Beaumont Health Systems studied the influence of bacterial virulence on clinical outcomes patients hospitalized with ILD patients.
Patient safety is a top priority at Martin Medical Center, which recently announced that it has seen a significant reduction in its Clostridium difficile (C.diff) infection rates since adopting Xenex LightStrike Germ-Zapping Robots as its environmental standard of care.
Without timely intervention, privacy curtains in hospitals can become breeding grounds for resistant bacteria, posing a threat to patient safety, according to new research published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.
As germs and bacteria become increasingly resistant to cleaning chemicals and antibiotics, Hunterdon Medical Center recently deployed Xenex LightStrike Germ-Zapping Robots that use pulsed xenon ultraviolet light to enhance traditional room cleaning procedures as a key part of the hospital's infection prevention program.
A new study has shown that some of the sub-strains of the bacteria that commonly live on our skin have become resistant to common infections – or in other words turned into superbugs. Infections with these strains thus could become untreatable with the antibiotics available and may turn life-threatening, warn researchers.
Researchers at Arizona State University and the Mayo Clinic in Rochester, Minnesota, have found that at least one type of blue clay may help fight disease-causing bacteria in wounds, including antibiotic-resistant bacteria. The findings appear in the International Journal of Antimicrobial Agents.
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.
The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company's president and chief executive officer, to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, Methicillin-Resistant Staphylococcus Aureus, and Ebola.
A germ-fighting robot that uses pulsed xenon ultraviolet (UV) light to sanitize rooms at Trinity Hospital is giving a boost to the hospital's infection control program.
Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.
After years of investigation, researchers at Johns Hopkins, the University of California, Davis, and the National Institute of Allergy and Infectious Diseases have discovered how the immune system might protect a person from recurrent bacterial skin infections caused by Staphylococcus aureus (staph).
An old drug supercharged by University of Queensland researchers has emerged as a new antibiotic that could destroy some of the world's most dangerous superbugs.
For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the body's immune system, offering a clearer picture of how a successful vaccine would work.
The introduction of methicillin into clinical practice is not what caused the emergence of methicillin resistant Staphylococcus aureus (MRSA), report researchers. According to a collaborative study by the University of St Andrews, University of Dundee and the Wellcome Trust Sanger Institute, MRSA existed long before clinicians started using the antibiotic.
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains.